# Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/reductions-in-afp-and-pivka-ii-can-predict-the-efficiency-of-anti-pd-1/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Xuqi Sun,Jie Mei,Wen‐Ping Lin,Ziliang Yang,Wei Peng,Jinbin Chen,Yaojun Zhang,Li Xu,Minshan Chen |
| Citations | 89 |
| DOI | 10.1186/s12885-021-08428-w |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-021-08428-w |
| OpenAlex ID | https://openalex.org/W3178910066 |
| PMID | 34218801 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Wei Peng](https://scholariq.org/researchers/wei-peng/)

## Paper journal

- [BMC Cancer](https://scholariq.org/journals/bmc-cancer/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.